Kris Fortman, PhD CEO of Minneapolis Heart Institute Foundation

Kris Fortman, PhD

Chief Executive Officer

As the CEO for MHIF, Kris provides visionary direction for the achievement of the organization’s mission, strategy, goals and objectives. She believes strongly in the legacy of innovation and collaboration. Every day, the MHIF vision of creating a world without heart and vascular disease is front and center.

Prior to joining MHIF, Kris served as the Director of Global Engagement at Medtronic Philanthropy. Under Kris’ leadership, Global Engagement underwent phenomenal growth and demonstrated impressive impact on communities around the globe. At the heart of Kris’ focus was the activation of 86,000 employees who channeled their time and resources toward health-focused community development and social investment.

Kris has built a track record in building effective teams, leading strategic initiatives, engaging diverse stakeholders, and translating complex science into meaningful stories. This is evident from her time building a research portfolio at HealthPartners Research Foundation, leading a team of scientists at Medtronic and most recently in her leadership at Medtronic Philanthropy. In her professional and personal life, she serves as a passionate advocate for improving community health. She currently serves on the board of the Minnesota Region of the American Red Cross, and an ex-officio member on the Abbott Northwestern Hospital Foundation Board.

Kris earned her bachelor’s degree from the College of St. Benedict, and holds an Interdisciplinary Ph.D. focused on Health Communication from Washington State University. She was a Policy Fellow at the Humphrey School of Public Affairs. Kris lives in White Bear Lake, Minn., with her husband and three sons.

Back to Board of Directors Back to Leadership Team

Twitter Icon
LinkedIn Icon
Kris Fortman, PhD CEO of Minneapolis Heart Institute Foundation
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.